<DOC>
	<DOCNO>NCT02125162</DOCNO>
	<brief_summary>The purpose study compare body take eliminates study drug BCX4161 take orally hard gelatin capsule soft gelatin capsule . This study also evaluate whether food effect body take BCX4161 .</brief_summary>
	<brief_title>A Study Relative Bioavailability New Formulation BCX4161 Effect Food BCX4161</brief_title>
	<detailed_description />
	<mesh_term>Angioedema</mesh_term>
	<mesh_term>Angioedemas , Hereditary</mesh_term>
	<criteria>Key Written inform consent Body mass index 19 32 kg/m2 weight least 50 kg Abide study restriction Attend study visit Acceptable birth control measure Key Clinically significant medical history , current medical psychiatric condition , ECG finding , laboratory/urinalysis abnormality Activated partial thromboplastin time prothrombin time outside normal laboratory limit Pregnant nursing Recent history alcohol abuse positive drug abuse screen Current smoker Donation loss great 400 mL blood within 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>BCX4161</keyword>
	<keyword>BioCryst</keyword>
	<keyword>hereditary angioedema</keyword>
	<keyword>relative bioavailability</keyword>
	<keyword>kallikrein inhibitor</keyword>
</DOC>